Recent health developments range from clinical breakthroughs in chronic disease management to significant public safety alerts.

Research presented at the American Thoracic Society suggests the 90-day CPAP adherence window for Medicare coverage is insufficient, as many patients achieve success within one year.

The FDA has strengthened warnings for the injectable drug Kybella, citing increased risks of facial numbness, weakness, and the formation of masses or nodules.

New blood tests for food allergies show promise in reducing false positives, though logistical challenges currently prevent their replacement of traditional food challenge tests.

Studies demonstrate that nurse-led interventions significantly improve patient outcomes, showing better metabolic control for adults with type 2 diabetes and superior asthma management in children.

Dupilumab has shown clinical efficacy in treating patients with severe chronic rhinosinusitis with nasal polyps, particularly those also suffering from eosinophilic otitis media.

A recent study indicates that performing a Cesarean section for very early preterm births is associated with higher rates of severe maternal complications compared to vaginal delivery.

Authorities in Nigeria report at least 49 deaths and 182 hospitalizations following a mass poisoning event linked to suspected tainted alcohol in Ondo state.